PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIRETROVIRAL DRUG AND PHARMACOKINETICS IMPROVER

摘要

FIELD: medicine.;SUBSTANCE: invention relates to a peroral or injectable pharmaceutical composition suitable for treatment of human immunodeficiency virus (HIV) usage, comprising a therapeutically effective amount of at least one antiretroviral drug, which contains reverse transcriptase inhibitor based on nucleotide analog (NRTI) selected from a group including: tenofovir alafenamide fumarate, tenofovir disoproxil fumarate, adefovir and a combination thereof; or (ii) protease inhibitor (PI) containing darunavir and a therapeutically effective amount of at least one activator or pharmacokinetics improver which contains piperine, tetrahydropiperine, cis-piperine, trans-piperine, cis,trans-piperine, trans,cis-piperine, cis,cis-piperine, trans,trans-piperine, or a combination thereof. Present invention also relates to a producing method of a peroral or injectable pharmaceutical composition, to a treatment kit for human immunodeficiency virus (HIV), to the usage of a combination for increasing the bioavailability of an oral antiretroviral drug, to a peroral or injectable pharmaceutical composition suitable for hepatitis B viruses treatment, to a treatment kit for hepatitis B viruses.;EFFECT: bioavailability of antiretroviral drugs enhancement. ;21 cl, 14 ex, 31 tbl, 8 dwg